Ascendis Pharma A/S - ADR Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.44250
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

200.97 -0.19 (-0.09%)

70.27% Gain from 52W Low

366.5K

XNAS Volume

XNAS 12 Nov, 2025 3:34 PM (EST)

Board Meeting

The next board meeting for Ascendis Pharma A/S - ADR is on 14 Nov 2025 for the purpose of Ascendis Pharma AS Third Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

5.0 / 100

Technically Neutral

52.7 / 100

251

1Yr Price target upside is 25%

15 analysts

Ascendis Pharma AS ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..